INTRODUCTION
Methionine is an amino acid essential for nucleic acid biosynthesis. Homocysteine is an important intermediate in methionine metabolism involving the enzyme methylenetetrahydrofolate reductase (MTHFR). Accumulation of homocysteine may result from a deficiency of vitamins involved in its metabolism (vitamin B 6 , B 12 , folic acid) or a mutation of genes encoding the enzyme methylenetetrahydrofolate reductase. Hyperhomocysteinemia is a known risk factor for atherosclerosis, 1 cardiovascular diseases, 2 stroke, 3 peripheral venous thrombosis 4 and neurodegenerative disease. 5 In pregnancy, it is postulated to be a risk factor for adverse outcomes like early pregnancy loss, 6 neural tube defects, 7 preeclampsia, 8 abruptio placenta 9 and intrauterine growth restriction. 10 Hyperhomocysteinemia has also been implicated as a factor for infertility. It is believed that hyperhomocysteinemia causes defective follicular Department of Obstetrics & Gynecology, King George's Medical University, Lucknow-226003, U.P., India development, oxidative damage to oocyte membrane, impairs chorionic villus vascularization, causes implantation failure and alters intrauterine milieu making it non-conducive for fertilization or implantation. 11, 12 The follicular fluid homocysteine level is a reflection of systemic homocysteine metabolism. 13 Studies of follicular fluid in women undergoing assisted reproduction suggest an inverse association between follicular fluid homocysteine levels and oocyte and embryo quality. 14, 15 Increased plasma and follicular homocysteine levels negatively correlate with oocyte maturation leading to a number of development defects of the oocyte that impede fertilization and/or the reproductive outcome in polycystic ovarian syndrome (PCOS) patients undergoing assisted reproduction. 16, 17 Hence, this study was planned to evaluate serum homocysteine levels, prevalence of MTHFR polymorphism in infertile women and to evaluate the role of hyperhomocysteinemia and MTHFR 677 C>T mutation in female infertility.
METHODS
This study was conducted in the department of Obstetrics and Gynecology of King George's Medical University (KGMU), Lucknow, over a period of 1 year, from September 2011 to August 2012 after approval by the institutional ethics committee. Women attending the Infertility Clinic at the department were enrolled. After taking informed consent a predesigned questionnaire was filled by the subjects including age, area of residence, dietary habits, parity, menstrual and obstetric history and type of infertility. A note was made regarding blood sugar levels, height and weight of the subjects and Body Mass Index. Important investigations like male partner's semen analysis, tubal patency tests/laparoscopic chromopertubation findings, serum levels of ThyroidStimulating Hormone, Prolactin, Follicle-stimulating Hormone and Luteinizing Hormone and pelvic ultrasound for polycystic ovaries were also documented. Ninety five infertile and 31 fertile women were enrolled for the purpose of this study. The samples were analyzed at Endocrinology department of Central Drug Research Institute (CDRI), Lucknow.
The subjects were categorized into groups depending on the cause of infertility as follows:
Group I -33 women with unexplained infertility (women with normal hormonal profile, normal uterine cavity and patent tubes proven by HSG Five ml of venous blood was drawn from each subject, 2 ml was collected in ethylenediaminetetraacetic acid vials and 3 ml in serum vials. The serum vials were centrifuged within 1 hour of collection in 'Spermfuge' at 2000 rpm, stored at 4 degree Centigrade and transported to CDRI at the earliest possible maintaining a proper cold chain. At CDRI, the serum vials were analyzed for homocysteine levels using the principle of adsorption with the decrease in adsorbance value of the sample at 340 nm due to oxidation of NADH to NAD + (Globe Diagnostics).
The EDTA vial samples were used for genetic study. Point mutation (677C>T) in the MTHFR gene was typed using direct DNA sequencing technique. Primers around the polymorphic site were designed with the help of GENETOOL software. PCR was carried out using Taq DNA polymerase enzyme in ABI Veriti thermal cycler (Applied Biosystems, USA). The amplified products were directly sequenced using BigDyeTM chain termination chemistry on ABI 3730 DNA analyzer followed by multiple alignment and sequence analysis using Auto Assembler Software (Applied Biosystems, USA).
The statistical analysis was done using SPSS (Statistical Package for Social Sciences) Version 15.0 statistical Analysis Software. Mean value for serum homocysteine was determined along with standard deviation. The characteristics of the patients and the mean plasma homocysteine concentrations between the infertile groups and fertile group were compared by Student's t test for unpaired data and between and within the different groups with the ANOVA. Allelic and genotypic frequencies were determined from observed genotype counts and differences in the genotype distribution between different groups were assessed by Pearson's χ 2 test of heterogeneity. Pearson correlation coefficient <0.05 was considered significant. Hardy Weinberg law of genetic equilibrium could not be evaluated due to small number of subjects included.
RESULTS
The subjects in the three infertile groups were comparable with each other as well as with the fertile group with respect to demographic parameters as depicted in Table 1 . The mean age of subjects in group II was slightly less when compared with the other infertile groups or when compared with the fertile group. Also significant was the higher percentage of vegetarians in group I as well as the fertile group. Group II had 18 cases of PCOS diagnosed on USG.
Serum homocysteine levels are normally in the range of 4 to 12 µmol/l. 18 Levels higher than 12 µmol/l are considered as hyperhomocysteinemia. In the present study, the mean serum homocysteine level was 16.21 ± 3.39 µmol/l, 16.36 ± 3.56 µmol/l, 16.98 ± 3.14 µmol/l for groups I, II and III respectively. For the fertile group, the mean serum homocysteine was 15.85 ± 2.63 µmol/l. The homocysteine levels were comparable for the study groups and difference with the fertile group was not statistically significant (F=0.669; P = 0.573). Eighteen cases of PCOS included in group II had a mean serum homocysteine level of 16.88 ± 3.10 µmol/l which was not statistically different from homocysteine levels of other women in group II (16.02 ± 3.62 µmol/l) or women included in group I, III and the controls.
The prevalence of hyperhomocysteinemia among infertile and fertile subjects is depicted in Table 2 . The prevalence of hyperhomocysteinemia was similar for the infertile groups as well as the fertile group. 
DISCUSSION
Subjects in the three infertile and the fertile groups in the present study were comparable with respect to demographic characteristics and hemodynamic parameters.
Of significance was the lower mean age (P <0.05) of females in group II compared with the other groups or the controls. This could be explained due to the fact that women in the anovulatory group presented earlier to infertility clinic due to associated menstrual irregularities.
Also, the higher percentage of vegetarians in group I and the infertile group was significant. Vegetarian diet is known to be deficient in vitamin B 12 , an important coenzyme in the methionine pathway. Its deficiency therefore can lead to hyperhomocysteinemia. However, in the present study, the prevalence of hyperhomocysteinemia was similar for all the groups irrespective of the dietary preferences. Vice-versa, among the subjects with hyperhomocysteinemia, the study did not reveal any significant difference in dietary preference. Table 3 represents the prevalence of vegetarian dietary preference among the subjects with hyperhomocysteinemia in the present study.
The study shows a very high prevalence of hyperhomocysteinemia in all the groups included. The prevalence of hyperhomocysteinemia was similar among the infertile groups and also when compared with the fertile subjects. Levels of serum homocysteine were also comparable for PCOS and non-PCOS women. The mean level of homocysteine for infertile women was around 16µmol/l for all the infertile groups. The levels were lower in the fertile group but nevertheless comparable. Since there was no statistically significant difference in homocysteine levels or prevalence of hyperhomocysteinemia between the infertile and fertile groups, no positive association could be established between hyperhomocysteinemia and female infertility.
The prevalence of homozygous and heterozygous mutation between the various infertile groups and fertile subjects were comparable. Heterozygous mutation of MTHFR enzyme results in 35% decrease and homozygous mutation causes a 70% reduction in enzyme activity. 19 Reduced enzyme activity impairs metabolism of folate intermediates leading to hyperhomocysteinemia. Of the subjects with hyperhomocysteinemia, 2 had homozygous MTHFR mutation and both belonged to group I. Heterozygous MTHFR mutation was present in 5, 7 and 5 subjects with hyperhomocysteinemia in the three infertile groups respectively. There were 6 cases of heterozygous MTHFR mutation among the fertile subjects (Table 4) . No statistically significant difference was observed in the prevalence of MTHFR mutations in infertile and fertile subjects with hyperhomocysteinemia. MTHFR mutation is a known cause for hyperhomocysteinemia which is believed to result in infertility. However, since the prevalence of MTHFR polymorphism was similar for the infertile groups and fertile controls, a positive role of this mutation in causing female infertility could not be established.
The study of Dubey et al. 20 conducted in a North India population with 30 cases of unexplained infertility and equal controls showed levels of serum homocysteine to be similar to the present study for the infertile group (17.27 µmol/l) but lower for fertile group (10.87 µmol/l). The study showed positive association between hyperhomocysteinemia and female infertility which was contrary to the present study.
A positive correlation between hyperhomocysteinemia and unexplained female infertility was also found in a study by Maristella D'Uva et al. 21 in a South Italian population which included 20 women with recurrent pregnancy loss, 20 with unexplained sterility and 20 healthy women controls. The mean serum homocysteine value in recurrent pregnancy loss group was 19.2 µmol/l, for the infertile group was 21.05µmol/l and that for controls was 7.85 µmol/l. These values were higher for cases and lower for controls when compared with the present study. Heterozygous MTHFR mutation was noted in 5/20 (25%) with unexplained infertility, 3/20 (15%) with recurrent loss and 9/20 (45%) controls. The homozygous MTHFR mutant was present in 15/20 (75%) with unexplained infertility, 17/20 (85%) with recurrent loss and 3/20 (15%) among controls.
Another study by Seema bibi et al. 22 in Pakistan showed that women suffering from unexplained subfertility had significantly higher homocysteine levels (12.8 µmol/l) as compared to controls (9.7 µmol/l). The authors concluded that hyperhomocysteinemia was positively associated with unexplained female subfertility. The same was not observed in the present study. Similarly, an inverse association between elevated homocysteine levels and fertility outcome was also established by the Dutch study of IMW Ebisch et al. 23 which evaluated follicular homocysteine levels (Fertile -14.7 nmol/mg protein, idiopathic subfertility -9.2 nmol/mg protein, tubal factor-9.8 nmol/mg protein, endometriosis -18.8 nmol/mg protein). As mentioned earlier, follicular fluid concentration of homocysteine is a reflection of systemic levels. The present study however did not show any similar results.
Similar to our study, Francesco Oreo Jr et al. 24 evaluated 70 women with PCOS and 70 healthy women in an Italian population for homocysteine levels and MTHFR polymorphism. The mean homocysteine levels were 11.3 µmol/l for the PCOS group and 12.2 µmol/l for controls, the difference being insignificant. Also, no difference was observed among cases and controls with respect to MTHFR prevalence although the prevalence of mutation was much higher than the present study (CT -58.5% PCOS, 54.3% controls; TT -18.6% PCOS and 21.4% controls). The study showed positive correlation between MTHFR mutation and raised homocysteine levels in healthy females but not for the women with PCOS. Considering the different MTHFR polymorphisms, no significant difference was observed in serum homocysteine levels between PCOS and controls. Insulin resistance was suggested to play a role in altering homocysteine metabolism only in PCOS without MTHFR polymorphism. Similarly Sills ES et al. 25 did not find a positive association between homocysteine levels and infertility in PCOS (n=54) in an American population and the levels were within the cut-off levels for both the cases as well as the fertile controls (n=18) (7 µmol/l for both groups).
On the other hand, Morey Schacter et al. 26 in the phenomenal Israeli study on 155 infertile PCOS and 100 normally ovulating women with infertility evaluated serum homocysteine levels found mean plasma homocysteine in the PCOS group to be significantly higher than in the normal ovulation group (11.5 vs. 7.4 µmol/l, P <0.001) and the levels were even higher in PCOS with insulin resistance. The study suggested that PCOS had other vascular-endothelial factors in addition to hyperhomocysteinemia that mandate evaluation, nevertheless, treatment of hyperhomocysteinemia improved conception and pregnancy outcomes in these women. Insulin resistance was proposed to affect serum homocysteine levels in PCOS. The present study found similar homocysteine levels in PCOS as well non-PCOS and controls.
The Indian study by Madhu Jain et al. 27 in 92 PCOS and 95 age matched controls for MTHFR polymorphism found a slightly higher prevalence of MTHFR heterozygous mutation in the cases (17.39%) when compared with the controls (13.68%) (OR-1.32). The percentage prevalence was however lower than the present study. The authors documented a higher, although statistically insignificant prevalence of heterozygous MTHFR polymorphism in PCOS along with an increased susceptibility for hyperlipidemia in presence of MTHFR polymorphism.
The present study shows a very high prevalence of hyperhomocysteinemia in subjects in infertile as well as the fertile groups. A major contribution could be attributed to the prevalence of vegetarian diet in this study as most of the subjects enrolled were vegetarians (83.6% of infertile subjects and 88.0% fertile subjects with hyperhomocysteinemia were vegetarians in the present study). Indian diet which comprises mainly of vegetarian dietary habits is poor in vitamin B 12 and other micronutrients which contribute significantly to the development of hyperhomocysteinemia. Thus, dietary factors appear to be significant in causing hyperhomocysteinemia. However, a definite role of hyperhomocysteinemia in causing female infertility was not established.
This study also demonstrates a significant prevalence of MTHFR mutation which may be responsible for hyperhomocysteinemia. However, analysis revealed high levels of homocysteine even in subjects with normal variant of MTHFR. Therefore, a positive association between MTHFR gene 677 C>T polymorphism and female infertility could not be substantiated in this analysis.
Thus, though diet largely and genetic factors in part appear to be responsible for hyperhomocysteinemia, the etiology for a significant portion remains obscure. Hyperhomocysteinemia appears to be endemic in this part of the country as is evident from the extremely high prevalence.
In this setting of endemic hyperhomocysteinemia, a correlation was not found between elevated homocysteine levels, MTHFR polymorphism and female infertility. There are views both in agreement with and against this result as discussed earlier and a definite role in causing female infertility is questionable.
This study has been conducted in a limited number of subjects therefore the results cannot be extrapolated to a larger population. Nevertheless, the trends of hyperhomocysteinemia have been similar to prior studies in the Indian subcontinent. A larger study is therefore needed to confirm and validate the findings in this study and help resolve issues related to hyperhomocysteinemia and infertility.
